These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 15194789)
21. STRUCTURAL AND FUNCTIONAL CHARACT ERISTICS OF THE LMP1 ONCOGENE IN PATIENTS WITH TUMORS ASSOCIATED AND NOT ASSOCIATED WITH THE EPSTEIN-BARR VIRUS. Senyuta NB; Smirnova KV; Diduk SV; Goncharova EV; Shcherbak LN; Gurtsevitch VE Mol Gen Mikrobiol Virusol; 2016 Sep; 34(2):71-75. PubMed ID: 30380210 [TBL] [Abstract][Full Text] [Related]
22. [Sequence analysis of the CTL epitopes in transmembrane region of latent membrane protein 2 of Epstein-Barr virus derived from nasopharyngeal carcinoma cells]. Zhang NH; Zhang XS; Li J; Zhang RH; Gao YF; Zeng MS Ai Zheng; 2006 May; 25(5):566-9. PubMed ID: 16687075 [TBL] [Abstract][Full Text] [Related]
23. Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma. Yoshizaki T; Kondo S; Wakisaka N; Murono S; Endo K; Sugimoto H; Nakanishi S; Tsuji A; Ito M Cancer Lett; 2013 Aug; 337(1):1-7. PubMed ID: 23689138 [TBL] [Abstract][Full Text] [Related]
24. Characterization of Epstein-Barr virus strains and LMP1-deletion variants in Portugal. Neves M; Marinho-Dias J; Ribeiro J; Esteves M; Maltez E; Baldaque I; Breda E; Monteiro E; Medeiros R; Sousa H J Med Virol; 2015 Aug; 87(8):1382-8. PubMed ID: 25879824 [TBL] [Abstract][Full Text] [Related]
25. Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais. Tiwawech D; Srivatanakul P; Karalak A; Ishida T J Clin Virol; 2008 May; 42(1):1-6. PubMed ID: 18180201 [TBL] [Abstract][Full Text] [Related]
26. Analysis of LMP1 variants of EBV in Southern Thailand: evidence for strain-associated T-cell tropism and pathogenicity. Saechan V; Mori A; Mitarnun W; Settheetham-Ishida W; Ishida T J Clin Virol; 2006 Jun; 36(2):119-25. PubMed ID: 16616610 [TBL] [Abstract][Full Text] [Related]
27. The LMP1 gene isolated from Russian nasopharyngeal carcinoma has no 30-bp deletion. Hahn P; Novikova E; Scherback L; Janik C; Pavlish O; Arkhipov V; Nicholls J; Müller-Lantzsch N; Gurtsevitch V; Grässer FA Int J Cancer; 2001 Mar; 91(6):815-21. PubMed ID: 11275985 [TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line. Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743 [TBL] [Abstract][Full Text] [Related]
29. [Analysis of Epstein-Barr virus with BamHI "f" variant and XhoI-loss of LMP1 gene in nasopharyngeal carcinoma]. Han AJ; Zong YS; Zhang M; Cao SM; Lin SX; Liang YJ Zhonghua Bing Li Xue Za Zhi; 2003 Dec; 32(6):534-8. PubMed ID: 14761599 [TBL] [Abstract][Full Text] [Related]
30. Biological properties of TW01 cells expressing latent membrane protein-1 gene of EBV-derived from nasopharyngeal carcinoma cells at different stages of malignancy. Tan EL; Sam CK Exp Oncol; 2007 Sep; 29(3):166-74. PubMed ID: 18004239 [TBL] [Abstract][Full Text] [Related]
31. Progression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma. Nakanishi Y; Wakisaka N; Kondo S; Endo K; Sugimoto H; Hatano M; Ueno T; Ishikawa K; Yoshizaki T Cancer Metastasis Rev; 2017 Sep; 36(3):435-447. PubMed ID: 28819752 [TBL] [Abstract][Full Text] [Related]
32. Potential selection of LMP1 variants in nasopharyngeal carcinoma. Edwards RH; Sitki-Green D; Moore DT; Raab-Traub N J Virol; 2004 Jan; 78(2):868-81. PubMed ID: 14694118 [TBL] [Abstract][Full Text] [Related]
33. [Sequence analysis of the deletion and mutation in carboxy terminal region of the Epstein-Barr virus latent membrane protein 1 derived from nasopharyngeal carcinoma patients]. Tang MZ; Zheng YM; Guo XC; Zhang YL; Zeng Y Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):35-8. PubMed ID: 12870015 [TBL] [Abstract][Full Text] [Related]
34. Ethnic differences in the expression of Epstein-Barr virus latent membrane protein-1 mutations in nasopharyngeal carcinoma. D'Addario M; Chauvin P Mutat Res; 2000 Dec; 457(1-2):69-78. PubMed ID: 11106799 [TBL] [Abstract][Full Text] [Related]
35. The Epstein-Barr virus latent membrane protein-1 (LMP1) 30-bp deletion and XhoI-polymorphism in nasopharyngeal carcinoma: a meta-analysis of observational studies. da Costa VG; Marques-Silva AC; Moreli ML Syst Rev; 2015 Apr; 4():46. PubMed ID: 25927427 [TBL] [Abstract][Full Text] [Related]
36. A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma. Knecht H; Martius F; Bachmann E; Hoffman T; Zimmermann DR; Rothenberger S; Sandvej K; Wegmann W; Hurwitz N; Odermatt BF Leukemia; 1995 Mar; 9(3):458-65. PubMed ID: 7885044 [TBL] [Abstract][Full Text] [Related]
38. LMP1 promoter sequence analysis in Epstein Barr virus pediatric infection reveals preferential circulation of B95.8 related variants in Argentina. Gantuz M; Lorenzetti MA; Altcheh J; De Matteo E; Moscatelli G; Moroni S; Chabay PA; Preciado MV Infect Genet Evol; 2013 Mar; 14():275-81. PubMed ID: 23305886 [TBL] [Abstract][Full Text] [Related]
39. Endogenous latent membrane protein 1 in Epstein-Barr virus-infected nasopharyngeal carcinoma cells attracts T lymphocytes through upregulation of multiple chemokines. Lai HC; Hsiao JR; Chen CW; Wu SY; Lee CH; Su IJ; Takada K; Chang Y Virology; 2010 Sep; 405(2):464-73. PubMed ID: 20637487 [TBL] [Abstract][Full Text] [Related]
40. Amino-acid change in the Epstein-Barr-virus ZEBRA protein in undifferentiated nasopharyngeal carcinomas from Europe and North Africa. Grunewald V; Bonnet M; Boutin S; Yip T; Louzir H; Levrero M; Seigneurin JM; Raphael M; Touitou R; Martel-Renoir D; Cochet C; Durandy A; Andre P; Lau W; Zeng Y; Joab I Int J Cancer; 1998 Feb; 75(4):497-503. PubMed ID: 9466647 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]